Solid-Phase vs. Liquid-Phase Peptide Synthesis

Peptide synthesis can be performed using different chemical strategies, but two of the most established approaches are solid-phase peptide synthesis (SPPS) and liquid-phase peptide synthesis (LPPS).

Both methods build peptide chains through the formation of peptide bonds between amino acids. However, they differ significantly in how the growing peptide is handled, how intermediates are separated, and how the overall process is scaled.

SPPS attaches the growing peptide chain to an insoluble resin, allowing excess reagents and by-products to be removed through washing and filtration. LPPS, by contrast, keeps the peptide or its protected intermediates in solution and relies on conventional separation and purification techniques between synthetic steps.

Today, SPPS is widely used for research, diagnostic, and pharmaceutical peptide production because it supports automation, diverse modifications, and efficient iterative synthesis. PeptiOrigin's current peptide synthesis platform also uses SPPS for customized peptide production and complex modified peptides.

However, liquid-phase synthesis remains relevant for certain peptide manufacturing strategies, particularly when peptide size, production scale, intermediate handling, or process economics make solution-based chemistry attractive.

Understanding the differences between these approaches can help researchers and manufacturers select an appropriate synthesis strategy for a specific peptide.

What Is Solid-Phase Peptide Synthesis?

Solid-phase peptide synthesis is a method in which the first amino acid is attached to an insoluble solid support, commonly referred to as a resin.

The peptide chain is then elongated one amino acid at a time.

A typical SPPS cycle involves:

1. Deprotection of the growing peptide

2. Washing

3. Addition of the next protected amino acid

4. Coupling

5. Washing

6. Repetition of the cycle

After the final amino acid has been incorporated, the peptide is cleaved from the resin and subjected to final deprotection when required. The resulting crude peptide is then purified and characterized.

PeptiOrigin describes this general sequence in its SPPS overview, including resin attachment, sequential coupling, deprotection, cleavage, HPLC purification, and analytical characterization.

The major advantage of this approach is that the growing peptide remains attached to the solid support while soluble reagents and many reaction by-products can be removed through repeated washing.

This makes repetitive peptide-bond formation much easier to automate.

What Is Liquid-Phase Peptide Synthesis?

Liquid-phase peptide synthesis takes place in solution rather than on an insoluble resin.

Instead of anchoring the growing peptide to a solid support, the peptide or protected peptide intermediate remains dissolved or suspended in the reaction medium.

After each coupling step, excess reagents and by-products must be separated from the desired intermediate.

This can involve techniques such as:

• Extraction

• Precipitation

• Filtration

• Crystallization

• Concentration

• Chromatographic purification

The process is then repeated for subsequent amino acid additions.

Because the growing peptide is not immobilized, solution-phase synthesis can provide useful flexibility for certain chemical processes. At the same time, repeated isolation and purification can become increasingly complicated as the peptide chain becomes longer.

SPPS vs. LPPS: The Fundamental Difference

The simplest distinction is where the growing peptide exists during synthesis.

The difference is more than a matter of equipment.

It changes how the entire synthesis process is designed.

How the Synthetic Cycle Differs

In SPPS, the growing peptide remains attached to the resin throughout most of the chain-assembly process.

This means that after a coupling reaction, excess amino acid and soluble reaction components can be removed by washing.

The process can therefore follow a repetitive pattern:

Deprotection → Washing → Coupling → Washing → Repeat

LPPS follows a different workflow.

After a coupling reaction, the desired peptide intermediate must be separated from excess reagents and side products before the next synthetic step.

A simplified process may look like:

Coupling → Separation → Purification → Isolation → Next Coupling

The difference becomes increasingly important as the number of synthetic steps increases.

Why SPPS Is Well Suited to Repetitive Peptide Assembly

Peptide synthesis requires multiple cycles of amino acid addition.

For a relatively short peptide, the number of cycles may already be substantial. Longer sequences require many more operations, and every additional step creates an opportunity for incomplete coupling or side reactions.

SPPS simplifies the operational side of this repetitive chemistry because the growing peptide remains immobilized.

The solid support effectively acts as a temporary physical separation mechanism.

Instead of isolating the peptide after every coupling, the operator can wash away soluble materials while retaining the peptide on the resin.

This feature is one reason SPPS became a cornerstone of modern peptide synthesis.

Purification Differences Between SPPS and LPPS

Purification is one of the most important distinctions between the two approaches.

In SPPS, purification is generally concentrated toward the end of the synthesis.

During chain assembly, washing steps remove many soluble reagents and by-products without requiring isolation of the peptide after every amino acid addition.

Once synthesis is complete, the crude peptide is cleaved from the resin and undergoes downstream purification.

PeptiOrigin identifies HPLC as a typical purification method following SPPS, followed by analytical techniques such as mass spectrometry or amino acid sequencing to confirm identity and quality.

In LPPS, intermediate purification can be incorporated throughout the synthesis.

This may provide opportunities to isolate and characterize intermediates, but it also adds handling and process steps.

For longer sequences, repeated isolation can increase process complexity.

How Peptide Length Influences the Choice

Peptide length is an important consideration when comparing synthesis strategies.

As additional amino acids are added, the number of coupling and protection steps increases.

For SPPS, the peptide remains attached to the resin throughout chain elongation, so the basic cycle can remain relatively consistent even as the sequence grows.

However, longer peptides can still present significant challenges.

They may experience:

• Incomplete coupling

• Aggregation

• Steric hindrance

• Difficult deprotection

• Sequence-dependent side reactions

• Lower overall yield

• More difficult purification

Therefore, SPPS does not eliminate the chemical challenges associated with long peptides.

Instead, it provides a practical framework for managing repetitive synthesis operations.

LPPS can also be used for peptide synthesis, but the increasing molecular size of solution-phase intermediates can make isolation, solubility, and purification progressively more demanding.

The Role of Automation

Automation is another major difference between modern SPPS and many traditional solution-phase processes.

Because SPPS consists of repetitive cycles, automated systems can control:

• Reagent addition

• Deprotection

• Coupling

• Washing

• Reaction timing

• Solvent delivery

• Process monitoring

This makes SPPS particularly useful for peptide libraries and high-throughput research.

PeptiOrigin's platform combines SPPS with customized peptide synthesis and large-scale peptide library capabilities, reflecting the compatibility of solid-phase chemistry with automated and parallelized workflows.

LPPS can also be automated, but the process may involve more complex liquid handling and intermediate isolation operations depending on the synthesis design.

SPPS and Complex Peptide Modifications

Modern peptide research often requires more than a simple linear sequence.

Researchers may request:

• N-terminal acetylation

• C-terminal amidation

• Fluorescent labels

• Biotinylation

• Lipidation

• Non-natural amino acids

• Cyclization

• Disulfide bonds

• Other site-specific modifications

SPPS can accommodate many of these modifications because functionalized building blocks can be incorporated during or after chain assembly.

This flexibility is particularly useful for research peptides, diagnostic reagents, and therapeutic development.

However, the presence of a modification does not automatically mean SPPS is the best solution.

The chemical compatibility of the modification, protection strategy, sequence, and purification requirements should all be evaluated.

When Liquid-Phase Synthesis Can Be Useful

Although SPPS is widely used, LPPS should not be viewed simply as an obsolete alternative.

Solution-phase chemistry can be advantageous in selected situations.

For example, LPPS may be considered when:

1. Large Quantities of a Specific Intermediate Are Needed

Some manufacturing processes may benefit from producing and isolating a protected peptide intermediate at scale.

2. Solubility Is Favorable

If the peptide intermediates remain sufficiently soluble and stable, solution-phase chemistry may be practical.

3. Convergent Synthesis Is Being Used

Longer peptides can sometimes be constructed by preparing protected peptide fragments separately and subsequently coupling them.

This strategy can combine elements of solid-phase and solution-phase chemistry.

4. Process Economics Favor Solution Chemistry

At larger production scales, solvent consumption, reagent usage, isolation efficiency, and equipment requirements can influence the economics of a synthesis route.

Therefore, process selection should be based on the complete manufacturing process rather than simply on whether a method is newer or more commonly used.

Convergent Peptide Synthesis: Combining Strategies

The comparison between SPPS and LPPS is not always binary.

Some advanced peptide manufacturing strategies combine different approaches.

For example, peptide fragments can be prepared separately and then joined through a convergent coupling strategy.

One segment may be synthesized using solid-phase chemistry, cleaved and purified, and then coupled with another protected fragment in solution.

This can be useful when the target molecule is too long or structurally complex for straightforward linear synthesis.

The important consideration is therefore not simply:

“SPPS or LPPS?”

A more useful question is:

“Which synthesis strategy provides the best balance of chemical feasibility, yield, purification, scalability, and product quality for this specific peptide?”

Yield: Why the Number of Steps Matters

Peptide synthesis is a sequential process, which means that the efficiency of individual steps influences the final outcome.

If each coupling step proceeds at less than complete conversion, small amounts of incomplete products can accumulate as the sequence grows.

This is a particular concern for longer peptides.

SPPS can simplify reagent removal and repetitive processing, but it does not eliminate incomplete coupling.

For this reason, process optimization may involve:

• Coupling reagent selection

• Amino acid equivalents

• Reaction time

• Temperature

• Solvent

• Resin loading

• Deprotection conditions

• Double-coupling strategies

• Sequence-specific optimization

The correct conditions depend heavily on the peptide sequence.

Resin Selection in SPPS

One of the characteristics unique to solid-phase synthesis is the need to select an appropriate resin.

Different resin systems can support different peptide-terminal structures and cleavage strategies.

Important resin-related considerations include:

• Resin type

• Loading capacity

• Swelling characteristics

• Compatibility with solvents

• Stability during synthesis

• Cleavage conditions

• Desired C-terminal functionality

Resin selection therefore forms part of the overall synthesis strategy rather than being simply a material choice.

An inappropriate resin can complicate coupling, swelling, cleavage, or downstream purification.

Cost Considerations

Comparing SPPS and LPPS purely on reagent price can be misleading.

The total cost of peptide production can include:

• Amino acid building blocks

• Coupling reagents

• Solvents

• Resin

• Protection and deprotection reagents

• Labor

• Equipment

• Intermediate isolation

• Purification

• Analytical testing

• Waste treatment

• Process development

SPPS may consume significant quantities of reagents and solvents because excess reagents are often used to drive coupling reactions toward completion.

However, the simplified washing and automation workflow can reduce intermediate handling.

LPPS may reduce or change certain material requirements, but repeated isolation and purification can add process complexity.

Consequently, the more meaningful comparison is total process cost per qualified peptide, rather than the cost of a single reagent or synthesis step.

Which Method Is Better for Research Peptides?

For many research applications, SPPS provides a practical combination of flexibility, automation, and compatibility with peptide modifications.

It is particularly useful when researchers need:

• Custom sequences

• Small to medium quantities

• Multiple sequence variants

• Modified peptides

• Peptide libraries

• Rapid design-to-material cycles

PeptiOrigin currently describes its SPPS capabilities as supporting research, diagnostics, drug discovery, vaccine-related studies, structural research, and pharmaceutical applications.

However, the actual method should still be selected according to the target peptide and required specifications.

Which Method Is Better for Large-Scale Production?

Scale introduces additional considerations.

At larger production volumes, manufacturers need to evaluate:

• Batch size

• Raw material consumption

• Solvent recovery

• Equipment capacity

• Waste generation

• Process safety

• Purification requirements

• Cycle time

• Reproducibility

• Regulatory requirements

SPPS is used at both research and larger production scales, but scale-up requires careful control of resin loading, mass transfer, mixing, heat transfer, reagent delivery, and purification.

LPPS can also be advantageous for selected industrial processes, particularly where solution-phase intermediates can be efficiently isolated and processed.

There is therefore no universal scale threshold at which one method automatically becomes preferable.

SPPS vs. LPPS: A Practical Decision Framework

When selecting a synthesis strategy, researchers and process developers can evaluate the following factors.

Peptide Length

Short sequences may be compatible with several synthetic strategies.

As sequence length increases, repetitive purification and intermediate isolation become increasingly important considerations.

Sequence Complexity

Hydrophobic sequences, aggregation-prone regions, sterically hindered residues, and unusual amino acids may require specialized process development.

Required Modifications

If the peptide contains multiple modifications, the compatibility of each modification with the protection and coupling strategy should be evaluated.

Quantity

The required peptide quantity can significantly influence process economics and equipment selection.

Purity Requirements

Research-grade, analytical, diagnostic, and pharmaceutical applications may require different purity and characterization specifications.

Purification

The expected impurity profile and purification difficulty should be considered before choosing the synthesis route.

Manufacturing Reproducibility

For repeated production, the selected method should support consistent synthesis and reliable analytical control.

A Simplified Comparison

The following summary provides a practical starting point:

The Key Difference Is Process Architecture

The most important distinction between SPPS and LPPS is not simply whether the peptide is “on a resin” or “in solution.”

It is the way the entire synthesis process is organized.

SPPS uses a solid support to simplify separation during iterative peptide assembly.

LPPS keeps the intermediates in solution and uses conventional separation and isolation operations throughout the process.

This fundamental difference affects:

• Reagent handling

• Purification

• Automation

• Process control

• Intermediate isolation

• Scale-up

• Cost

• Manufacturing strategy

Final Thoughts

Solid-phase and liquid-phase peptide synthesis are both established approaches, but they address peptide manufacturing challenges in different ways.

SPPS is particularly valuable when repetitive synthesis, automation, custom sequences, peptide libraries, and structural modifications are important. By keeping the growing peptide attached to a solid support, it simplifies the removal of soluble reagents during chain assembly and supports efficient iterative synthesis.

LPPS can remain useful for selected synthesis routes where solution-phase chemistry, intermediate isolation, fragment coupling, or manufacturing economics provide specific advantages.

The right choice ultimately depends on the peptide itself.

Sequence length, amino acid composition, structural complexity, modifications, desired quantity, purity requirements, purification strategy, and manufacturing scale should all be considered before selecting the synthesis route.

For researchers and biotechnology companies developing custom peptides, understanding these differences can make early process decisions more informed and can help identify potential synthesis and purification challenges before production begins.

PeptiOrigin's current peptide synthesis platform combines SPPS capabilities with custom peptide synthesis, purification, analytical verification, and support for complex and modified peptides, providing an integrated approach for research and pharmaceutical applications.